TrialInternational journal of clinical oncology2017
Response to the treatment immediately before nivolumab monotherapy may predict clinical response to nivolumab in patients with non-small cell lung cancer.
Haruki Kobayashi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it